{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "decreases_activity",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "go:GO:0006955",
      "entity_text" : "immune surveillance",
      "entity_type" : "bioprocess"
    },
    "participant_a" : {
      "in_model" : true,
      "identifier" : "uniprot:Q99707",
      "entity_text" : "MS",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false
  },
  "verbose_text" : "Several multiple sclerosis (MS) therapies impair immune surveillance to various degrees and may predispose patients to develop community acquired and opportunistic infections.",
  "reading_complete" : "2020-07-28T14:50:44Z",
  "reader_type" : "machine",
  "reading_started" : "2020-07-28T14:49:08Z",
  "trigger" : "impair",
  "evidence" : [ "MS) therapies impair immune surveillance" ],
  "pmc_id" : "7256606",
  "score" : 0
}